Risperidone augmentation therapy in patients who have failed or only partially responded to an adequate trial of antidepressant

Trial Profile

Risperidone augmentation therapy in patients who have failed or only partially responded to an adequate trial of antidepressant

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Risperidone (Primary)
  • Indications Depression; Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Aug 2007 The expected completion date for this trial is now 1 Feb 2005.
    • 30 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top